Results 221 to 230 of about 387,972 (242)

Polyvalent interaction of antibodies with bacterial cells

Molecular Immunology, 1990
We have studied the physical-chemical characteristics of the interaction of peroxidase-labelled rabbit antibodies with Bacillus sp. bacterial cells. The antibodies are able to bind bivalently with two antigen sites on the bacterial cells with the formation of intramolecular "cyclic" complexes.
, Karulin AYu, B B, Dzantiev
openaire   +2 more sources

ANTIBODIES AS INDICATORS FOR BACTERIAL SURFACE STRUCTURES

Annual Review of Microbiology, 1956
Antibodies have been used very extensively for the detection, isolation, and identification of the ceIJular components of bacteria. This work could be applied, however, only in part to an evaluation of the topography of immuno­ chemically defined components in the cellular architecture.
openaire   +2 more sources

Antibodies to bacterial L-asparaginases.

The New Zealand medical journal, 1978
Complement fixation has been shown to occur when asparaginase reacts with specific antibody. This is as a result of an antigenic determinant common to the four bacterial asparaginases. Patients on asparaginase therapy may produce antibodies and these could be demonstrated by complement fixation.
K M, Elhag, K A, Bettelheim, T J, Huber
openaire   +1 more source

Measuring Antibody Orientation at the Bacterial Surface

2016
Many bacteria have the ability to interact with antibodies as a means to circumvent the immune response. This includes binding to the Fc portion of antibodies, effectively reversing the antibody orientation and thus decreasing the Fc-mediated immune signaling.
Oonagh, Shannon, Pontus, Nordenfelt
openaire   +2 more sources

Antibody coated bacteria in ejaculatein bacterial prostatitis

Urology, 1984
In patients with bacteriologically proved prostatitis (Stamey test) ejaculate was examined for antibody-coated bacteria (ACB). Forty-four of the 68 patients (65%) with bacteriologically proved prostatitis had ACB in the ejaculate, but only 7 of 89 patients (8%) with prostatodynia.
G, Riedasch, K, Möhring, E, Ritz
openaire   +2 more sources

Bacterial antibodies in ankylosing spondylitis.

Clinical and experimental immunology, 1991
Antibodies to Salmonellae, Yersiniae, Campylobacter jejuni, Borrelia burgdorferi, Klebsiella pneumoniae, Escherichia coli, Proteus mirabilis and Chlamydia trachomatis were measured by ELISA in the sera of 99 patients with ankylosing spondylitis. Increased prevalence of IgA and IgG class antibodies against K. pneumoniae and of IgA class against E.
O, Mäki-Ikola, K, Lehtinen, K, Granfors, R, Vainionpää, P, Toivanen   +4 more
openaire   +1 more source

Bacterial Expression of Anti-DNA Antibody Domains

Methods, 1997
Bacterial production of recombinant Fab or Fv domains of antibodies is an important tool for analyzing structural correlates of antigen binding or idiotype expression. Bacterial products may be Fab or Fv molecules that assemble from separate chains in the periplasm or a single-chain Fv protein.
openaire   +2 more sources

Expression of Single-Domain Antibodies in Bacterial Systems

2012
In this chapter we describe in detail the current protocols that are used to express single-domain antibodies in bacteria. Bacteria are among the most common expression systems for expressing recombinant proteins. We present different approaches for carrying out periplasmic and cytoplasmic expression, as well as small-scale and large-scale expression ...
Baral, T.N., Arbabi-Ghahroudi, M.
openaire   +3 more sources

Antibody Immunotherapy of Gram‐negative Bacterial Sepsis

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
Gram‐negative bacterial sepsis continues to represent a significant cause of morbidity and mortality in hospitalized patients. Currently available medical therapy (antimicrobial agents, hemodynamic monitoring, aggressive fluid resuscitation, and nutritional support) for this disease process has reduced but not eliminated the severe
openaire   +2 more sources

Anti-bacterial monoclonal antibodies: Back to the future?

Archives of Biochemistry and Biophysics, 2012
Today's medicine has to deal with the emergence of multi-drug resistant bacteria, and is beginning to be confronted with pan-resistant microbes. This worsening inadequacy of the antibiotics concept, which has ruled infectious medicine in the last six decades creates an increasing unmet medical need that can be addressed by passive immunization.
Martin B, Oleksiewicz, Gábor, Nagy, Eszter, Nagy   +2 more
openaire   +2 more sources